Immunization has saved six lives a minute. Every minute. For five decades.

Let’s not stop now. Speak up and tell leaders it’s time for immunization for all.

Let’s show the world what’s #HumanlyPossible

World Health Organization (WHO) UNICEF Gates Foundation

Vaccines are among the most powerful inventions in history, making once-feared diseases preventable.

With continued research, investment and collaboration, we can save millions more lives today and in the next 50 years. #HumanlyPossible

#WorldImmunizationWeek

Congratulations Benin, Liberia and Sierra Leone for launching large-scale rollouts of the world’s first malaria vaccine targeting millions of children! bit.ly/3UAAnIN #WorldMalariaDay

World Health Organization (WHO), UNICEF, GSK, Unitaid, The Global Fund, MedAccess, @PATHTweets, USAID Global Health

Explore The Viral Most Wanted—The Hantaviruses to learn more about this group of viruses, including how they operate, who they affect, and the lines of enquiry being pursued to help stop future outbreaks.

cepi.net/hantaviruses

The Hantavirus family—behind diseases like Hantavirus Pulmonary Syndrome—has two distinct subgroups: the Old World Hantaviruses, found in Africa, Asia, & Europe, and the New World Hantaviruses, found in the Americas.

Learn more in The Viral Most Wanted ➡️cepi.net/hantaviruses

In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year.

The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in…

The Poxviruses is a large family of more than 70 viruses that can infect both people and animals.

Read CEPI’ deepdive into the prime suspects of this viral family: bit.ly/3JdtWow

'The Poxviruses are some of the best known and most feared viruses on earth. The most notorious and deadly suspect within the viral family is Variola, the agent of Smallpox.'

Learn more about this viral family in #TheViralMostWanted 🔎➡️ cepi.net/poxviruses

Why is the need for speed in vaccine manufacturing so crucial to outbreak response, and what is CEPI doing to accelerate these timelines?

Find out ⬇️

bioprocessintl.com/global-markets…

“I told them it is not witchcraft, it is a virus.”

Last week, we announced the CEPI-funded first-ever Phase 2 Lassa vaccine trial led by IAVI (bit.ly/3TE0mxa).

Science Magazine explores this virus which has plagued West Africa for >50 years science.org/content/articl…

Varsity four tops Yale and Cornell at Cayuga Cup

📰 bit.ly/3PT5MTI

From the historical—and now non-existent—Smallpox outbreaks to the very current and growing Mpox outbreaks, the Poxvirus family is the source for some of the most feared viral epidemics to have hit humankind.

Explore The Viral Most Wanted—The Poxviruses to find out more about…

On #WorldHealthDay , let's celebrate the power of vaccines—from polio to COVID-19, vaccines have saved millions of lives worldwide.

But much work remains. Find out more about CEPI's work to develop vaccines against our priority diseases below ⬇️ bit.ly/4aFggOI

The promise of a Lassa fever vaccine draws ever closer with the announcement of a CEPI-funded first-ever Phase 2 vaccine trial launched by IAVI at @HJFMRI’s trial site in Abuja, Nigeria 🇳🇬

The The Guardian Nigeria reports on this new research milestone ⬇️ guardian.ng/news/nigerians…

Big news for science and public health with the first Ph2 trial of a Lassa vaccine candidate.

Personally proud to see this start in Nigeria, & look forward to the expansion to other countries.

One step closer, the journey continues.

Parasites are amazingly cunning. So is there any hope of developing vaccines against them? Really enjoyed researching this @Gavi piece on how vax against leishmaniasis, hookworm, schistosomiasis are increasingly within reach gavi.org/vaccineswork/h…

New discovery of cause for asthma sparks hope for treatments, scientists say. Interesting study funded by Wellcome independent.co.uk/news/health/sc…

📣A CEPI-funded first-ever Phase II Lassa vaccine trial has been launched by IAVI in Nigeria.

The trial at @HJFMRI in Abuja is designed in consultation with partners including NCDC and the Nigeria Lassa Vaccine Taskforce.

cepi.net/participants-n…

In the article, he references Kate Kelland's book, DISEASE X: The 100 Days Mission to End Pandemics, and the pure good sense of investing in a comprehensive vaccine library to give us a head start against pathogens with epidemic or pandemic potential, helping to contain outbreaks…

Al-Shifa hospital in #Gaza this morning, following the end of the latest Israeli siege.

I repeat: hospitals must be respected and protected; they must not be used as battlefields.